Given the role of redox mechanisms in tumor cell proliferation coupled with the role of Nrf2 in cellular antioxidant defense mechanisms [23], we first questioned whether Nrf2 induction in glioma cells modulates cellular proliferation. This evidence concerns the gene NFE2L2 and central nervous system cancer.